CIMT 2009: report on the seventh annual meeting of the association for immunotherapy of cancer
- 75 Downloads
CIMT 2009 was the seventh annual meeting organized by the Cancer Immunotherapy (CIMT) Association and attracted an audience of about 400 international scientists to meet in Mainz and discuss recent developments in the field of cancer immunotherapy. Focus of this year’s meeting were basic and translational aspects of antigen-specific immunotherapy and the monitoring of immune responses with three dedicated sessions organized by the recently founded committee of the CIMT Immunoguiding Program (CIP). The newly initiated CIMT working group on regulatory research organized a session dedicated to regulatory aspects of drug development in which perspectives from academia, consultants, industry and regulatory authorities were presented. The current meeting report summarizes selected presentations providing a broad overview on the scientific content covered at the meeting.
Mechanisms of immune activation and immune suppression
The innate immune system is the first line of defense against RNA...
KeywordsMelanoma Patient Fluorescence Resonance Energy Transfer Ipilimumab Cancer Immunotherapy iNKT Cell
The authors would like to thank Dr. B.P. Davies (Mainz, Germany) for carefully proof reading the meeting report.